2.3.14 Trace Elements and the Liver

50 Pan Q, Bao LW, Merajver SD (2003) Tetrathiomolybdate inhibits angiogenesis and metastasis through suppression of the NFkappaB signaling cascade. Mol Cancer Res 1 (10), 701–706. 51 Border WA, Noble NA (1994) Transforming growth factor beta in tissue fibrosis. N Engl J Med 331 (19), 1286–1292. 52 Brewer GJ, Ullenbruch MR, Dick RB et al. (2003) Tetrathiomolybdate therapy protects against bleomycin-induced pulmonary fibrosis in mice. J Lab Clin Med 141 (3), 210–216. 53 Brewer GJ, Dick R, Ullenbruch MR et al. (2004) Inhibition of key cytokines by tetrathiomolybdate in the bleomycin model of pulmonary fibrosis. J Inorg Biochem 98 (12), 2160–2167. 54 Askari FK, Dick RB, Mao M et al. (2004) Tetrathiomolybdate therapy protects against concanavalin A and carbon tetrachloride hepatic damage in mice. Exp Biol Med 229 (8), 857–863. 55 Ma S, Hou G, Dick RD et al. (2004) Tetrathiomolybdate protects against liver injury from acetaminophen in mice. J Appl Res Clin Exp Ther 4 (3), 419–426. 56 Elliott MJ, Maini RN, Feldmann M et al. (1993) Treatment of rheumatoid arthritis with chimeric monoclonal antibodies to tumor necrosis factor alpha. Arthritis Rheum 36 (12), 1681–1690. 57 Shanahan JC, St Clair W (2002) Tumor necrosis factor-alpha blockade: a novel therapy for rheumatic disease. Clin Immunol 103 (3 Pt 1), 231–242. 58 D’Haens G, Van Deventer S, Van Hogezand R et al. (1999) Endoscopic and histological healing with infliximab anti-tumor necrosis factor antibodies in Crohn’s disease: a European multicenter trial. Gastroenterology 116 (5), 1029–1034. 59 Mease PJ, Goffe BS, Metz J et al. (2000) Etanercept in the treatment of psoriatic arthritis and psoriasis: a randomised trial. Lancet 356 (9227), 385–390. 60 Elner SG, Elner VM, Yoshida A et al. (2005) Effects of tetrathiomolybdate in a mouse model of retinal neovascularization. Invest Ophthalmol Vis Sci 46 (1), 299–303.